Fujifilm Sonosite to Investigate Role of Point-of-Care Ultrasound in COVID-19 Patients Through Clinical Research
By HospiMedica International staff writers
Posted on 16 Sep 2020
FUJIFILM Sonosite, Inc. (Bothell, WA, USA) and the CHEST Foundation, the charitable foundation of the American College of Chest Physicians (Glenview, IL, USA), have announced their joint grant in creating the CHEST Foundation Research Grant in Ultrasonography and COVID-19. Posted on 16 Sep 2020
Although early studies report that point-of-care ultrasound (POCUS) is providing numerous benefits to intensive care clinicians caring for COVID-19 patients, additional research on the efficacy in the management of this deadly virus is critical. The objective of the grant is to investigate the role of POCUS technology on COVID-19 patients through clinical research. FUJIFILM Sonosite is contributing up to two grants of USD 30,000 to the CHEST Foundation in support of the joint program and will also donate its newly-launched Sonosite PX ultrasound systems to the selected research award sites.
"COVID-19 continues to negatively affect the health of people around the globe and overwhelm health care systems," said Diku Mandavia, Senior Vice President, Chief Medical Officer of FUJIFILM Sonosite. "As a company that is focused on providing innovative, point of care ultrasound technology to healthcare providers, we're excited to host a joint grant with the CHEST Foundation. This research grant will investigate how POCUS can help in COVID-19 ICU care and has the potential to build upon the current evidence."
"As the pandemic continues to sweep the world, our goal is to help accelerate research efforts including the role of imaging modality innovations in the diagnosis and management of patients with COVID-19," said CHEST Foundation President Edward J. Diamond.